Research - News
Diseases linked to atherosclerosis are the leading cause of death in the United States.
The new, one-of-a-kind center has a vision of improving the health and function of people with disabilities through encouraging access, increasing participation, and promoting adherence to recreation, exercise and sports.
UAB Nutrition researchers are investigating whether calorie restriction or intermittent fasting can slow the aging process.
A four-year grant from NIH will fund a clinical trial that will test new approaches to cognitive rehabilitation in adults with stroke.
Given the rising rates of obesity and diabetes, semaglutide could be used effectively to reduce the burden of these chronic diseases.
New funding will advance research on the role of diet and race in knee arthritis pain and pain sensitivity, respectively, in transgender community.
The study will examine a protein that may help slow bleeding in the brain when given within a two-hour window following the first signs of hemorrhage.
The follow-up study will take a bench-to-bedside approach
The UAB Marnix E. Heersink School of Medicine leadership team outlined key research focus areas to ensure continued growth over the next five to seven years.
This novel finding will help guide successful therapeutic design and strategies for acute kidney injury and chronic kidney disease.
Knockout of TXNIP improves diabetes-associated hyperglycemia and hyperglucagonemia.
Published results suggest the COVID-19 pandemic exacerbated the slow increase in pediatric Type 2 diabetes.
New research seeks to navigate therapeutic resistance for glioblastoma, a type of a severe brain cancer.
The clinically approved drug ruxolitinib suppressed a mouse model of melanoma that is resistant to immune checkpoint blockers.
The UAB projects will investigate was to improve and increase the use of artificial intelligence in biomedical research.
Owsley and McGwin will lead three data collection sites in the collection of data to inform machine learning approaches to provide critical insights into the endemic condition Type 2 diabetes mellitus.
The study, an exception from informed consent trial, will compare whole blood to blood components in the treatment of traumatic injuries.
UAB researchers show there is no longer a connection between the previously linked gene and elevated blood pressure in those of African ancestry.
UAB is participating in a multi-center clinical trial that will dig deeper into the connection between hypertension and salt intake.
Noninvasive ventilation is possible in infants at limits of viability. But unlike in slightly older preterm infants, noninvasive ventilation did not show an advantage in infants of 22 weeks-0 days to 23 weeks-6 days gestational age.
Researchers from UAB and other institutions are seeking to better understand the aging differences between males and females.
Carbohydrates are directly linked to the development of Type 2 diabetes, but a higher-carb diet is underused in research models.
The new technique to predict seizure clusters could, if confirmed, have a profound impact on patients with drug-resistant epilepsy who are prone to seizure clusters.
Persuasion knowledge is triggered by sponsorship disclosures, which may have adverse effects on a brand’s trustworthiness, a UAB study suggests.
Social media has been a useful tool to inform a community about research studies that are exempt from informed consent protocols.
The study seeks to determine whether prothrombin complex concentrate, a blood-clotting agent, could help save the lives of patients at risk for severe bleeding after injury.
Zhang wins $11.2 million NIH PPG grant to improve heart attack recovery through growth of new heart muscle cells.
This is the first study to examine mistreatment from patients across the entire clinical team and to examine the experience of gender and sexual minorities.
The deciphering of a new signaling cascade sheds light on how mutations in metabolism cause normal cells to become cancerous.
Results published in the Journal of Alzheimer’s Disease show patients with one cancer diagnosis were less likely to develop dementia and had an overall slower cognitive decline than patients with no history of cancer.